| 前收盘价格 | 0.018 |
| 收盘价格 | 0.018 |
| 成交量 | 10,000 |
| 平均成交量 (3个月) | 211,811 |
| 市值 | 15,983,261 |
| 价格/销量 (P/S) | 1.99 |
| 股市价格/股市净资产 (P/B) | 4.30 |
| 52周波幅 | |
| 利润日期 | 23 Aug 2024 |
| 营业毛利率 | -138.79% |
| 营业利益率 (TTM) | -96.82% |
| 稀释每股收益 (EPS TTM) | -0.010 |
| 季度收入增长率 (YOY) | 39.00% |
| 总债务/股东权益 (D/E MRQ) | 140.10% |
| 流动比率 (MRQ) | 0.780 |
| 营业现金流 (OCF TTM) | -5.57 M |
| 杠杆自由现金流 (LFCF TTM) | -3.84 M |
| 资产报酬率 (ROA TTM) | -30.36% |
| 股东权益报酬率 (ROE TTM) | -173.93% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (SG) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | IX Biopharma | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | 0.13 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| IX BIOPHARMA | 16 M | - | - | 4.30 |
| TJ DARENTANG USD | 3 B | 52.24% | 5.44 | 1.65 |
|
iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are Specialty Pharmaceutical and Nutraceutical business segments. The firm's business segments operate in United States of America, Singapore, Australia, and China, of which the majority of the revenue comes from the United States of America. The company generates the majority of its revenue from the sale of specialty pharmaceutical products. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 50.56% |
| 机构持股比例 | 0.09% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Lee (Yip Hang Eddy) | 04 Sep 2024 | 217,000,852 (24.57%) |
| HRT Corporation Pte. Ltd. | 04 Sep 2024 | 66,748,029 (7.56%) |
| Tang (Choy Leng Jane) | 04 Sep 2024 | 22,793,565 (2.58%) |
| Narulla (Jaspal Singh) | 04 Sep 2024 | 20,727,047 (2.35%) |
| Tan (See Tee) | 04 Sep 2024 | 17,470,800 (1.98%) |
该时间范围内无数据。
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 23 May 2025 | 公告 | General Announcement::Notice of End of Conversion Period and Maturity Date of Convertible Bonds |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合